Ipratropium Uses, Dosage, Side Effects and Interactions
Atrovent
Atrovent was the first ipratropium product the FDA approved, in December 1986. An FDA-approved generic with the same active ingredient is listed.
Atrovent HFA
Atrovent HFA came 17 years after Atrovent (November 2004) as an inhaler. An FDA-approved generic with the same active ingredient is listed.
Ipratropium is an anticholinergic medicine used to treat bronchospasm (airway tightening) in COPD and to relieve a runny nose caused by the common cold or seasonal allergic rhinitis.
Quick links
Ask Anything About IpratropiumType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Ipratropium in Short
- Drug class Anticholinergic How the FDA classifies it
What it treatsIpratropium is available in inhaled and nasal forms, each approved for different conditions. The inhaled forms — including Atrovent HFA and ipratropium bromide inhalation aerosol and solution — are used as maintenance (ongoing) bronchodilators for people with chronic obstructive pulmonary disease (COPD), including…
- How you get it Prescription only
- Comes asNasal spray, inhalation solution (nebulizer) and inhalerAvailable strengths
Nasal spray (in the nose)
- 21 mcg
- 42 mcg
Inhalation solution (nebulizer) (inhaled)
- 0.5 mg/2.5 mL
Inhaler (inhaled)
- 17 mcg
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- What pharmacies pay
- Generic$0.38 to $0.78 per mL of the spray bottle’s contents
- Inhalation solution (nebulizer), generic: $0.10 to $0.11 per mL of the inhaler’s contents
The pharmacy’s own cost, national average. Not your price See every price+ 2 more price detailsShow fewer price details
- Inhalers, generic: $21.67 per gram of the inhaler’s contents
- Inhalers, Atrovent: $22.76 per gram of the inhaler’s contents
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Ipratropium (Atrovent), an older anticholinergic on the U.S. market since about 1986 with FDA-approved generics listed, blocks the nerve signal acetylcholine, relaxing tight airways when inhaled for COPD and drying up mucus glands when sprayed for a runny nose from colds or hay fever. Little reaches the bloodstream, so it is well tolerated beyond dry mouth, a bitter taste or headache. If breathing suddenly tightens right after an inhaled dose (paradoxical bronchospasm, a rare reaction), stop it and call your doctor right away. Mention glaucoma or an enlarged prostate first, and keep sprays out of your eyes, since it can raise eye pressure and make urinating hard.
Key Takeaways From the HelloPharmacist Team
- For COPD, use it every day on schedule, the inhaler four times a day or the nebulizer three to four times a day.
- Keep a quick-relief inhaler such as albuterol for sudden breathing attacks, because inhaled ipratropium is daily maintenance, not a rescue medicine.
- Expect the nasal spray to stop dripping, not stuffiness or sneezing; for a cold, the label covers only four days of use.
- Avoid stacking it with other anticholinergic drugs, including some bladder medicines like oxybutynin, which multiply dry mouth and trouble urinating.
Patient Information Guide for Ipratropium
What It’s Used For
Ipratropium is available in inhaled and nasal forms, each approved for specific conditions. Here is the full set of supported uses:
- COPD maintenance (inhaled aerosol — Atrovent HFA): Atrovent HFA is approved as a bronchodilator for ongoing management of bronchospasm associated with COPD, including chronic bronchitis and emphysema.
- COPD maintenance (inhaled aerosol — Ipratropium Bromide Inhalation aerosol): Ipratropium Bromide Inhalation aerosol is approved for maintenance treatment of bronchospasm associated with COPD, including chronic bronchitis and emphysema.
- COPD maintenance (nebulizer solution — Ipratropium Bromide): Ipratropium Bromide inhalation solution (nebulizer) is approved for maintenance treatment of bronchospasm associated with COPD, including chronic bronchitis and emphysema — used alone or with other bronchodilators, especially beta-adrenergic medicines.
- Runny nose from the common cold (nasal spray — Ipratropium Bromide): Ipratropium Bromide nasal spray 0.06% is approved for symptomatic relief of rhinorrhea (runny nose) from the common cold in adults and children aged 5 and older; approved for up to 4 days.
- Runny nose from seasonal allergic rhinitis (nasal spray — Ipratropium Bromide): Ipratropium Bromide nasal spray 0.06% is approved for symptomatic relief of rhinorrhea from seasonal allergic rhinitis in adults and children aged 5 and older; approved for up to 3 weeks.
How It Works
Ipratropium is an anticholinergic medicine, meaning it blocks the action of acetylcholine — a chemical your nervous system uses to signal muscles and glands. In the lungs, blocking this signal prevents the airways from tightening, which makes it easier to breathe. In the nose, it reduces activity in the mucus-producing glands lining the nasal passages, which cuts down on a runny nose. Because ipratropium is a quaternary amine — a chemical structure that doesn't cross easily into the bloodstream or the brain — most of its action stays local, at the site where it's applied, and whole-body (systemic) anticholinergic side effects are much less common than with older medicines in this class.
Drug Class
Drug Class
- Anticholinergic
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Anticholinergic
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Cholinergic Antagonists
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Ipratropium in the FDA’s index.
From our Patient Information GuideIpratropium is an anticholinergic medicine, meaning it blocks the action of acetylcholine — a chemical your nervous system uses to signal muscles and glands. Read How Ipratropium Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)None listed for Ipratropium in the FDA’s index.
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Other nasal preparations
- Anticholinergics
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
How often and how you take ipratropium depends entirely on the specific product. The inhaled aerosol forms (Atrovent HFA and Ipratropium Bromide Inhalation aerosol) are taken multiple times a day by inhaling through the mouth; the nebulizer solution is also used multiple times daily, with doses spaced through the day.
The nasal spray is sprayed into each nostril several times a day, for a short course only. None of these products are taken with food — they go directly into the lungs or nose.
- Do not exceed the maximum daily dose listed on your product label or prescribed by your doctor.
- The inhaled forms are for maintenance use only — not for sudden breathing emergencies.
- The nasal spray is short-term: no more than 4 days for a cold, or 3 weeks for seasonal allergies.
- If you miss a dose, take it as soon as you remember, but do not double up — just follow your regular schedule and ask your pharmacist if unsure.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Ipratropium Inhalation Solution (Nebulizer)
Airway tightening (bronchospasm) from COPD, including chronic bronchitis and emphysema
For adults
Usual dose 500 mcg (1 Unit-Dose Vial) three to four times a day
- 500 mcg (1 Unit-Dose Vial) administered three to four times a day by oral nebulization, with doses 6 to 8 hours apart
Good to know
Can be mixed in the nebulizer with albuterol or metaproterenol if used within one hour
Atrovent
Airway tightening (bronchospasm) from COPD, including chronic bronchitis and emphysema
For adults · Starting dose
Starting dose Two inhalations four times a day
Highest dose 12 inhalations in 24 hours
- Patients may take additional inhalations as required
Ipratropium Bromide 42 Mcg Nasal Spray
Runny nose from the common cold or seasonal allergies
Adults and children 12 years and older (common cold) Usual dose Two sprays (84 mcg) per nostril three or four times daily
- Two sprays (84 mcg) per nostril three or four times daily (total dose 504 to 672 mcg/day)
Good to know
Optimum dosage varies with response of the individual patient; safety and effectiveness beyond four days not established
Adults and children 5 years and older (seasonal allergies) Usual dose Two sprays (84 mcg) per nostril four times daily
- Two sprays (84 mcg) per nostril four times daily (total dose 672 mcg/day)
Good to know
Safety and effectiveness beyond three weeks not established
Children 5 to 11 years old (common cold) Usual dose Two sprays (84 mcg) per nostril three times daily
- Two sprays (84 mcg) per nostril three times daily (total dose of 504 mcg/day)
Good to know
Safety and effectiveness beyond four days not established
Ipratropium Bromide 21 Mcg Nasal Spray
Runny nose from year-round allergic or nonallergic rhinitis
For adults and children 6 years and older
Usual dose Two sprays (42 mcg) per nostril two or three times daily
- Two sprays (42 mcg) per nostril two or three times daily (total dose 168 to 252 mcg/day)
Good to know
Optimum dosage varies with the response of the individual patient
Side Effects
The most common side effects reported across ipratropium products include:
Common side effects
- Dry mouth
- Headache
- Bronchitis or worsening COPD symptoms
- Shortness of breath (dyspnea)
- Nausea
- Dizziness
- Bitter taste in the mouth
- Sinus irritation or congestion
- Bronchitis or COPD flares
- Upset stomach (dyspepsia)
When to get medical help
- Call your doctor right away if you have sudden worsening of breathing or wheezing after using the inhaler — this could be paradoxical bronchospasm, a rare but serious reaction
- Seek emergency help if you have signs of a severe allergic reaction: hives, swelling of the face, lips, tongue or throat, or trouble swallowing
- Contact your doctor if you notice eye pain, blurred vision, halos around lights, or redness in the eyes — these may be signs of increased pressure in the eye (narrow-angle glaucoma)
- Tell your doctor if you have trouble urinating or feel like your bladder doesn't empty fully
- Seek care if you experience rapid or irregular heartbeat
Warnings and Precautions
- Not for acute attacks: The inhaled forms are maintenance medicines — they are not rescue inhalers for sudden breathing emergencies. Always have a fast-acting rescue medicine available if your doctor has prescribed one.
- Paradoxical bronchospasm: Rarely, ipratropium can cause airways to tighten instead of opening — a potentially life-threatening reaction. Stop the medicine immediately and seek care if this happens.
- Eye pressure risk: Ipratropium can raise pressure inside the eye and worsen narrow-angle glaucoma. Do not get the spray or aerosol in your eyes. Seek care immediately if you notice eye pain, blurred vision, or halos around lights.
- Urinary retention: Men with an enlarged prostate and anyone with a bladder obstruction should use ipratropium cautiously — it can make urination difficult. Tell your doctor if this becomes a problem.
- Severe allergic reactions: Anaphylaxis (a life-threatening allergic response) has been reported. Stop the medicine and get emergency help if you develop swelling of the face, lips, tongue, or throat, or have trouble breathing.
Interactions
Ipratropium has a key interaction to know about:
- Other anticholinergic medicines: Taking ipratropium together with other anticholinergic drugs can add up their effects — increasing the risk of dry mouth, difficulty urinating, and eye pressure problems. Avoid combining them unless your doctor specifically approves it.
- Nebulizer combinations (inhalation solution only): Ipratropium Bromide inhalation solution can be mixed with albuterol or metaproterenol in the nebulizer if used within one hour. Mixing with other drugs in the nebulizer has not been established as safe and should be avoided.
Interactions Listed in the FDA-Approved Label
From the Ipratropium prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Sympathomimetic bronchodilators, methylxanthines, oral and inhaled steroidsWhat happensUsed together with ipratropium HFA in COPD; apart from albuterol, no formal studies fully evaluate safety and effectiveness of these combinations.
-
Anticholinergic medicationsWhat happensPotential for an additive interaction, which may increase anticholinergic adverse effects.What to doAvoid coadministration of ipratropium bromide HFA inhalation aerosol with other anticholinergic-containing drugs.
Read the label’s full interactions text
Drug Interactions: No controlled clinical trials were conducted to investigate potential drug-drug interactions. There is potential for an additive interaction with other concomitantly administered medications with anticholinergic properties, including Ipratropium Bromide Nasal Solution 0.06% (Nasal Spray) for oral inhalation.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Allergy to ipratropium or atropine: Do not use ipratropium if you are allergic to it, atropine, or any of its derivatives — this is a contraindication.
- Narrow-angle glaucoma: Use with caution; ipratropium can raise eye pressure and worsen this condition.
- Enlarged prostate or bladder obstruction: Use with caution; ipratropium can cause or worsen difficulty urinating.
- Pregnancy: Inhaled ipratropium is negligibly absorbed into the bloodstream, so fetal exposure is expected to be very low. Published studies have not identified a drug-related risk of major birth defects. Still, discuss with your doctor.
- Breastfeeding: Ipratropium levels in breast milk are expected to be low given how little is absorbed after inhalation. Discuss the benefits and risks with your doctor.
- Children: The inhaled aerosol forms have not been established as safe and effective in children. The nasal spray is approved for children aged 5 and older.
- Older adults (65+): Studies show similar effectiveness and safety in older adults compared to younger patients — no dose adjustment is specifically noted, but discuss your full health picture with your prescriber.
- Liver or kidney disease: The pharmacokinetics of ipratropium have not been studied in people with liver or kidney problems; let your doctor know if you have these conditions.
Overdose
An overdose from the nasal spray is unlikely because ipratropium is poorly absorbed through the nasal lining and the gut. In studies, even large oral doses did not significantly change heart rate or blood pressure. If someone accidentally swallows a large amount or uses far more than prescribed, contact Poison Control or seek medical care right away as a precaution.
Half-Life and How Your Body Processes It
Ipratropium is poorly absorbed — less than 20% enters the bloodstream after nasal use, and only 2–3% is absorbed after swallowing, which is why systemic side effects are uncommon. Once in the body, it is minimally bound to proteins in the blood and does not cross into the brain. It is partially broken down by the body into inactive products, and about half of an intravenous dose is excreted unchanged in the urine within 24 hours. The half-life (the time for half the drug to clear the body) is approximately 1.6 hours after intravenous dosing.
Storage
Store tightly closed at 20° to 25°C (68° to 77°F) . Avoid freezing. Keep out of reach of children.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ipratropium: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Ipratropium — the kind of thing our pharmacy team would talk through with you at the counter.
My doctor gave me an ipratropium inhaler — can I use it when I have a sudden asthma attack?
The nasal spray helps my runny nose, but can I keep using it past a week?
I got some of the inhaler spray in my eye by accident — is that a big deal?
I take another medication for my bladder — is that okay to combine with ipratropium?
Will the ipratropium nasal spray help with my stuffy nose and sneezing too?
I'm pregnant — is it safe for me to use the ipratropium inhaler?
Is ipratropium available over the counter?
When was ipratropium first available?
Who makes ipratropium?
What is the brand name of ipratropium?
What is the generic name of Atrovent?
What drug class is ipratropium?
Is there a generic version of ipratropium?
What strengths does ipratropium come in?
How much does ipratropium cost?
Is there a ipratropium shortage?
Where can I read the ipratropium prescribing information (package insert)?
Is ipratropium gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Ipratropium
Skip the scrolling. Ask in your own words and get an answer from Ipratropium’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Ipratropium’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Ipratropium on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, usually within a day.Ipratropium Forms and Strengths (How It Comes)
Ipratropium comes in 3 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Ipratropium inactive ingredients by manufacturer.
Nasal spray
How this form is used
- Ipratropium Bromide nasal spray 0.06% is used to relieve a runny nose (rhinorrhea) caused by the common cold in adults and children aged 5 and older
- Ipratropium Bromide nasal spray 0.06% is used to relieve a runny nose (rhinorrhea) caused by seasonal allergic rhinitis in adults and children aged 5 and older
- Ipratropium Bromide nasal spray does not relieve nasal congestion or sneezing
- Ipratropium Bromide nasal spray requires initial priming with 7 sprays before first use; reprime with 2 sprays if unused for more than 24 hours, or 7 sprays if unused for more than 7 days
- Avoid spraying Ipratropium Bromide nasal spray into your eyes
- For colds, use Ipratropium Bromide nasal spray for no more than 4 days; for seasonal allergic rhinitis, use for no more than 3 weeks
- Follow your prescriber's or label instructions for the number of sprays per nostril and how many times per day
Inhalation solution (nebulizer)
How this form is used
- Ipratropium Bromide inhalation solution is used as a maintenance bronchodilator for bronchospasm associated with COPD, including chronic bronchitis and emphysema
- Ipratropium Bromide inhalation solution can be used alone or alongside other bronchodilators, especially beta-adrenergic medicines
- Ipratropium Bromide inhalation solution is taken by nebulizer, inhaled through the mouth, typically three to four times a day with doses spaced 6 to 8 hours apart
- Ipratropium Bromide inhalation solution may be mixed in the nebulizer with albuterol or metaproterenol only if used within one hour of mixing
- Do not mix Ipratropium Bromide inhalation solution with other drugs in the nebulizer, as safety of other combinations has not been established
- Follow your prescriber's instructions for dosing; do not change the frequency without guidance
Inhaler
How this form is used
- Atrovent HFA is used as a maintenance bronchodilator for bronchospasm associated with COPD, including chronic bronchitis and emphysema
- Ipratropium Bromide Inhalation aerosol is used as a maintenance bronchodilator for bronchospasm associated with COPD, including chronic bronchitis and emphysema
- Atrovent HFA and Ipratropium Bromide Inhalation aerosol are for oral inhalation only — inhaled through the mouth, not the nose
- Atrovent HFA and Ipratropium Bromide Inhalation aerosol are solution aerosols that do not require shaking, but coordination between pressing the canister and inhaling is important
- Prime Atrovent HFA or Ipratropium Bromide Inhalation aerosol before first use by releasing 2 test sprays into the air; reprime with 2 sprays if the inhaler has not been used for more than 3 days
- Avoid spraying Atrovent HFA or Ipratropium Bromide Inhalation aerosol into your eyes; discard the inhaler after the labeled number of actuations
Ipratropium on the U.S. Market: Products, Makers and Brands
How Ipratropium appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
24 companies list 35 Ipratropium product records with the FDA, mostly as nasal spray, inhalation solution (nebulizer), inhaler; the earliest marketing or approval year on record is 1986. Brand names in the directory today include Atrovent and Atrovent HFA; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (11) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Ipratropium Is Used (Medicaid Data)
How many Ipratropium prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Ipratropium prescribed? Of the 1,666 medications we measure, Ipratropium ranks #247 by Medicaid prescriptions — more than 85% of them.
Utilization by Ipratropium product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
ipratropium bromide 0.2 MG/ML Inhalation Solution Most dispensed
20 of 48 listed NDCs had Medicaid claims. RxNorm 836358
ipratropium bromide 0.042 MG/ACTUAT Metered Dose Nasal Spray
7 of 11 listed NDCs had Medicaid claims. RxNorm 1797844
ipratropium bromide 0.021 MG/ACTUAT Metered Dose Nasal Spray
7 of 9 listed NDCs had Medicaid claims. RxNorm 1797833
200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler
1 of 4 listed NDCs had Medicaid claims. RxNorm 836343
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 35 of the 72 listed Ipratropium NDCs had Medicaid claims.
Compare Ipratropium Products
A representative set of FDA-listed product records for Ipratropium — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Inhalation solution (nebulizer) | ||||
| 0.5 mg/2.5 mL | Respiratory (inhalation) | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 0.5 mg/2.5 mL | Respiratory (inhalation) | American Health Packaging | ANDA | View NDC → |
| 0.5 mg/2.5 mL | Respiratory (inhalation) | Aurobindo Pharma Limited | ANDA | View NDC → |
| 0.5 mg/2.5 mL | Respiratory (inhalation) | Cardinal Health 107, LLC × 2 listings | ANDA | View NDC → |
| 0.5 mg/2.5 mL | Respiratory (inhalation) | Chartwell RX, LLC | ANDA | View NDC → |
| 0.5 mg/2.5 mL | Respiratory (inhalation) | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 0.5 mg/2.5 mL | Respiratory (inhalation) | Nephron Pharmaceuticals Corporation | ANDA | View NDC → |
| 0.5 mg/2.5 mL | Respiratory (inhalation) | NuCare Pharmaceuticals, Inc. | ANDA | View NDC → |
| 0.5 mg/2.5 mL | Respiratory (inhalation) | Redpharm Drug | ANDA | View NDC → |
| 0.5 mg/2.5 mL | Respiratory (inhalation) | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 0.5 mg/2.5 mL | Respiratory (inhalation) | Ritedose Pharmaceuticals, LLC | ANDA | View NDC → |
| 0.5 mg/2.5 mL | Respiratory (inhalation) | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 💊Inhaler | ||||
| 17 mcg | Respiratory (inhalation) | Armstrong Pharmaceuticals, Inc. | ANDA | View NDC → |
| 17 mcg | Respiratory (inhalation) | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | View NDC → |
| 💊Nasal spray | ||||
| 42 mcg | Nasal | A-S Medication Solutions | ANDA | View NDC → |
| 21 mcg | Nasal | Advagen Pharma Ltd | ANDA | View NDC → |
| 42 mcg | Nasal | Advagen Pharma Ltd | ANDA | View NDC → |
| 21 mcg | Nasal | Amneal Pharmaceuticals NY LLC | ANDA | View NDC → |
| 42 mcg | Nasal | Amneal Pharmaceuticals NY LLC | ANDA | View NDC → |
| 21 mcg | Nasal | Apotex Corp. | ANDA | View NDC → |
| 42 mcg | Nasal | Apotex Corp. | ANDA | View NDC → |
| 21 mcg | Nasal | Bausch & Lomb Incorporated | ANDA | View NDC → |
| 42 mcg | Nasal | Bausch & Lomb Incorporated | ANDA | View NDC → |
| 21 mcg | Nasal | Bryant Ranch Prepack | ANDA | View NDC → |
| 42 mcg | Nasal | Bryant Ranch Prepack | ANDA | View NDC → |
| 21 mcg | Nasal | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 42 mcg | Nasal | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 21 mcg | Nasal | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 42 mcg | Nasal | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 21 mcg | Nasal | Northstar Rx Llc | ANDA | View NDC → |
| 42 mcg | Nasal | Northstar Rx Llc | ANDA | View NDC → |
| 42 mcg | Nasal | Oceanside Pharmaceuticals | ANDA | View NDC → |
| 42 mcg | Nasal | Sportpharm LLC | ANDA | View NDC → |
Showing 35 of 35 products — FDA National Drug Code Directory. See every product, package size and price: browse all 35 Ipratropium NDCs →
Ipratropium Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Ipratropium — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Ipratropium in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Ipratropium FDA Approval History
How Ipratropium went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Ipratropium Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list one Ipratropium recall since July 2021. It is no longer listed as ongoing. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- Ipratropium Bromide Inhalation Solution, 0.02%, 0.5 mg/2.5 mL, packaged in 25-count box (25 x 2.5 mL sterile unit-dose vials), Rx only, MFG: Nephron Pharma, NDC 0487-9801-25 Lots: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that i… FDA record D-1040-2022 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 12, 2026.
Ipratropium in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 3
- Strengths
- 4
- Forms in current FDA listings
- 3 of 3
RxCUI 7213 -
Dose form (SCDF) Inhalation SolutionIn current FDA listings
RxCUI 2108449Its strength (SCD)-
0.2 mg/mL
bromide
RxCUI 836358
-
0.2 mg/mL
bromide
-
Dose form (SCDF) Metered Dose InhalerIn current FDA listings
RxCUI 746447Its strength (SCD)-
200 actuation ipratropium bromide 0.017 mg/actuation
RxCUI 836343
-
200 actuation ipratropium bromide 0.017 mg/actuation
-
Dose form (SCDF) Metered Dose Nasal SprayIn current FDA listings
RxCUI 1797832Its 2 strengths (SCD)-
0.021 mg/actuation
bromide
RxCUI 1797833 -
0.042 mg/actuation
bromide
RxCUI 1797844
-
0.021 mg/actuation
bromide
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Ipratropium Supply and Shortage Status
Whether Ipratropium is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Ipratropium Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Ipratropium: the national average from CMS’s weekly NADAC survey, as of Nov 11, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick a form, the generic or the brand, and a strength to see how its price has changed since Oct 2023.
For the generic 21 mcg nasal spray, pharmacies paid an average of $0.381 per mL as of Nov 11, 2026, down 28% from $0.527 a year earlier.
- What pharmacies pay now
- $0.381
- per mL, as of Nov 11, 2026
- Last 4 weeks
- Up 3.6%
- from $0.368 on Oct 14, 2026
- Last 12 months
- Down 28%
- from $0.527 on Nov 12, 2025
- Lowest and highest since Oct 2023
- $0.349 to $0.705
- per mL
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $0.381 |
| Oct 2026 | $0.381 |
| Sep 2026 | $0.368 |
| Aug 2026 | $0.355 |
| Jul 2026 | $0.349 |
| Jun 2026 | $0.366 |
| May 2026 | $0.386 |
| Apr 2026 | $0.399 |
| Mar 2026 | $0.405 |
| Feb 2026 | $0.420 |
| Jan 2026 | $0.434 |
| Dec 2025 | $0.449 |
| Nov 2025 | $0.482 |
| Oct 2025 | $0.527 |
| Sep 2025 | $0.571 |
| Aug 2025 | $0.618 |
| Jul 2025 | $0.615 |
| Jun 2025 | $0.614 |
| May 2025 | $0.574 |
| Apr 2025 | $0.575 |
| Mar 2025 | $0.573 |
| Feb 2025 | $0.551 |
| Jan 2025 | $0.510 |
| Dec 2024 | $0.509 |
| Nov 2024 | $0.447 |
| Oct 2024 | $0.582 |
| Sep 2024 | $0.625 |
| Aug 2024 | $0.660 |
| Jul 2024 | $0.534 |
| Jun 2024 | $0.625 |
| May 2024 | $0.518 |
| Apr 2024 | $0.524 |
| Mar 2024 | $0.696 |
| Feb 2024 | $0.701 |
| Jan 2024 | $0.705 |
| Dec 2023 | $0.612 |
| Nov 2023 | $0.700 |
| Oct 2023 | $0.660 |
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Nasal spray · Nasal | 21 mcg | Generic | $0.381 per mL | NDC details & price history |
| Nasal spray · Nasal | 42 mcg | Generic | $0.777 per mL | NDC details & price history |
| Inhalation solution (nebulizer) · Respiratory (inhalation) | 0.5 mg/2.5 mL | Generic | $0.103–$0.114 per mL | NDC details & price history |
| Inhaler · Respiratory (inhalation) | 17 mcg | Generic | $21.67 per gram | NDC details & price history |
| Inhaler · Respiratory (inhalation) | 17 mcg | Atrovent (brand) | $22.76 per gram | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Ipratropium Brand Names
Ipratropium has 2 brand names on record: Atrovent and Atrovent HFA. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Ipratropium: Manufacturers and Labelers
24 companies list Ipratropium products with the FDA. By number of product records, the largest are A-S Medication Solutions, Advagen Pharma Ltd, Amneal Pharmaceuticals NY LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Ipratropium Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Lupin Pharmaceuticals, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →